Antitumour Drug Induced Cardiovascular Toxicity and Current Tumour Treatment Methods
Currently the oncological mortality takes the second place globally, the leading cause being cardiovascular diseases. The statistics of malignant neoplasms is rather negative all over the world. 10 million of cases of oncological disorders are diagnosed annually; this means that 27 million people fa...
Saved in:
| Main Authors: | K. S. Gumerova, G. M. Sakhautdinova, I. M. Polyakova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bashkir State Medical University
2020-01-01
|
| Series: | Креативная хирургия и онкология |
| Subjects: | |
| Online Access: | https://www.surgonco.ru/jour/article/view/436 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The cardiovascular system in patients with anthracycline cardiomiopathy
by: Alexandr T. Teplyakov, et al.
Published: (2017-10-01) -
Therapeutic Potential of Ginsenosides in Anthracycline-Induced Cardiotoxicity
by: Rongrong Bai, et al.
Published: (2025-06-01) -
Overview of Oncology: Drug-Induced Cardiac Toxicity
by: Nilima Rajpal Kundnani, et al.
Published: (2025-04-01) -
Impact of Chemotherapy Alone and in Combination with Immunotherapy on Oral Microbiota in Cancer Patients—A Pilot Study
by: Adriana Padure, et al.
Published: (2025-07-01) -
Challenges in the implementation of cardio-oncology trials: lessons learnt from investigating statins in the prevention of anthracycline cardiotoxicity
by: John Lee, et al.
Published: (2024-12-01)